{"filing":{"accession_number":"0001193125-26-335092","cik":"0001531177","ticker":"SGHT","company_name":"Sight Sciences, Inc.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"sght-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1531177/000119312526335092/sght-20260805.htm"},"events":[{"id":24732,"run_id":22426,"accession_number":"0001193125-26-335092","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Sight Sciences issued a press release on August 5, 2026 announcing Q2 2026 financial results with revenue of $23.4 million (20% YoY growth) and raised full-year 2026 revenue guidance to $88–$92 million while reducing adjusted operating expense guidance to $92–$94 million.","company_name":"Sight Sciences, Inc.","ticker":"SGHT","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":25389,"accession_number":"0001193125-26-335092","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Sight Sciences issued a press release on August 5, 2026 announcing Q2 2026 financial results (revenue of $23.4 million, 20% YoY growth) and raising full-year 2026 revenue guidance to $88–$92 million while reducing adjusted operating expense guidance to $92–$94 million. The disclosure is a standard quarterly earnings announcement with detailed financial metrics, segment performance, and forward guidance, furnished as Exhibit 99.1 under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:17:00.529729+00:00","company_name":"","ticker":null,"filing_date":""},{"id":25390,"accession_number":"0001193125-26-335092","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure references an investor presentation posted on August 5, 2026, but the substantive content furnished as Exhibit 99.1 is a comprehensive earnings release reporting Q2 2026 financial results (revenue of $23.4 million, 20% YoY growth), along with raised full-year 2026 revenue guidance ($88–$92 million) and reduced adjusted operating expense guidance ($92–$94 million). This is a classic earnings release with detailed financial metrics, segment performance, and forward guidance that would materially affect investor assessment of the company's financial performance and trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:17:00.529729+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25389,"accession_number":"0001193125-26-335092","item_number":"2.02","item_title":"Results of Operations and Financial Condition","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Sight Sciences issued a press release on August 5, 2026 announcing Q2 2026 financial results (revenue of $23.4 million, 20% YoY growth) and raising full-year 2026 revenue guidance to $88–$92 million while reducing adjusted operating expense guidance to $92–$94 million. The disclosure is a standard quarterly earnings announcement with detailed financial metrics, segment performance, and forward guidance, furnished as Exhibit 99.1 under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:17:00.529729+00:00","company_name":"Sight Sciences, Inc.","ticker":"SGHT","filing_date":"2026-08-05"},{"id":25390,"accession_number":"0001193125-26-335092","item_number":"7.01","item_title":"Regulation FD Disclosure","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure references an investor presentation posted on August 5, 2026, but the substantive content furnished as Exhibit 99.1 is a comprehensive earnings release reporting Q2 2026 financial results (revenue of $23.4 million, 20% YoY growth), along with raised full-year 2026 revenue guidance ($88–$92 million) and reduced adjusted operating expense guidance ($92–$94 million). This is a classic earnings release with detailed financial metrics, segment performance, and forward guidance that would materially affect investor assessment of the company's financial performance and trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:17:00.529729+00:00","company_name":"Sight Sciences, Inc.","ticker":"SGHT","filing_date":"2026-08-05"}]}